《沪深两市》上证半日偏软深成回升1% 内险股受压 汽车股造好
中国10月官方制造业及非制造业PMI均胜预期。人行今日单日零投放零回笼。人币中间价上调182点，报6.7050兑一美元。上证深成高开後走个别。
上证半日微跌1点，收报3,222点；深成升132点或1%，收报13,368点；沪深300指数升17点或0.4%，收报4,712点；创业板指数升40点或1.5%，收报1,443点，成交2,754亿元。两市成交分别为2,019亿元人民币(下同)及3,012亿元。
银行股个别走，工行(601398.SH)升0.4%。建行(601939.SH)跌0.6%。保险股受压，国寿(601628.SH)、新华保险(601336.SH)分别跌3.3%、5.1%。
部份券商股先升後回，国联证券(601456.SH)跌停。方正证券(601901.SH)、华泰证券(601688.SH)、中泰证券(600918.SH)跌2.4%-3.4%。中国银河(601881.SH)则升4%。
《新能源汽车产业发展规划》拟今日发布，刺激汽车及新能源汽车股继续造好，渤海汽车(600960.SH)、江铃汽车(000550.SZ)涨停。先导智能(300450.SZ)扬9.8%。比亚迪(002594.SZ)、长城汽车(601633.SH)、东风汽车(600006.SH)、北汽蓝谷(600733.SH)、盛弘股份(300693.SZ)、特锐德(300001.SZ)升3.2%-6.4%。
家电龙头股造好，美的集团(000333.SZ)、格力电器(000651.SZ)分别升6.5%、3%。
生物疫苗股续跌，昭衍新药(603127.SH)跌停。华兰生物(002007.SZ)挫9.8%。康泰生物(300601.SZ)、博晖创新(300318.SZ)、君正集团(601216.SH)跌4%-4.6%。
半导体股个别发展，紫光国微(002049.SZ)跌5.2%。中芯国际(688981.SH)、汇顶科技(603160.SH)各跌0.5%。捷捷微电(300623.SZ)、韦尔股份(603501.SH)分别升3.8%及5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
